Organogenesis
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $101,005 | $86,693 | $126,656 | $115,177 |
Gross Profit | 66,720 | 62,970 | 95,605 | 88,381 |
EBITDA | -12,576 | -26,746 | 14,641 | 10,698 |
EBIT | -31,032 | 10,192 | 6,294 | |
Net Income | -9,392 | -21,591 | 7,673 | 12,331 |
Net Change In Cash | 101,005 | 86,693 | 126,656 | 115,177 |
Free Cash Flow | -36,511 | -23,561 | 7,576 | 6,126 |
Cash | 73,076 | 109,965 | 135,571 | 94,340 |
Basic Shares | 126,853 | 126,295 | 132,162 | 133,926 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $482,043 | $433,140 | $450,893 | $468,059 |
Gross Profit | 366,302 | 326,659 | 345,874 | 353,860 |
EBITDA | 15,763 | 36,031 | 40,322 | 86,998 |
EBIT | -1,263 | 12,582 | 22,291 | 70,322 |
Net Income | 861 | 4,945 | 15,532 | 94,202 |
Net Change In Cash | 482,043 | 433,140 | 450,893 | 468,059 |
Cost of Revenue | -11,238 | 29,722 | ||
Free Cash Flow | 4,176 | 6,553 | -9,039 | 30,758 |
Cash | 135,571 | 104,338 | 102,478 | 113,929 |
Basic Shares | 131,673 | 132,746 | 132,383 | 133,662 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.10 |
2025-03-31 | -$0.17 |
2024-12-31 | $0.06 |
